Israel · Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 618.59 million. The enterprise value is 430.08 million.
| Market Cap | 618.59M |
| Enterprise Value | 430.08M |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 12.42% |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 11.13.
| PE Ratio | 11.13 |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 13.48 |
| P/OCF Ratio | 8.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.64, with an EV/FCF ratio of 9.37.
| EV / Earnings | 7.74 |
| EV / Sales | 0.46 |
| EV / EBITDA | 4.64 |
| EV / EBIT | 9.52 |
| EV / FCF | 9.37 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.83 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.45 |
| Debt / FCF | 1.02 |
| Interest Coverage | 27.06 |
Financial Efficiency
Return on equity (ROE) is 8.35% and return on invested capital (ROIC) is 8.58%.
| Return on Equity (ROE) | 8.35% |
| Return on Assets (ROA) | 3.51% |
| Return on Invested Capital (ROIC) | 8.58% |
| Return on Capital Employed (ROCE) | 7.57% |
| Weighted Average Cost of Capital (WACC) | 3.64% |
| Revenue Per Employee | 5.14M |
| Profits Per Employee | 306,934 |
| Employee Count | 181 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 4.08 |
Taxes
In the past 12 months, Ilex Medical has paid 18.58 million in taxes.
| Income Tax | 18.58M |
| Effective Tax Rate | 25.06% |
Stock Price Statistics
The stock price has decreased by -11.12% in the last 52 weeks. The beta is -0.11, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -11.12% |
| 50-Day Moving Average | 5,863.94 |
| 200-Day Moving Average | 6,261.63 |
| Relative Strength Index (RSI) | 38.07 |
| Average Volume (20 Days) | 3,352 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 930.83 million and earned 55.56 million in profits. Earnings per share was 4.97.
| Revenue | 930.83M |
| Gross Profit | 211.88M |
| Operating Income | 55.81M |
| Pretax Income | 74.14M |
| Net Income | 55.56M |
| EBITDA | 89.16M |
| EBIT | 55.81M |
| Earnings Per Share (EPS) | 4.97 |
Balance Sheet
The company has 235.11 million in cash and 46.60 million in debt, with a net cash position of 188.51 million or 16.85 per share.
| Cash & Cash Equivalents | 235.11M |
| Total Debt | 46.60M |
| Net Cash | 188.51M |
| Net Cash Per Share | 16.85 |
| Equity (Book Value) | 684.71M |
| Book Value Per Share | 61.20 |
| Working Capital | 468.27M |
Cash Flow
In the last 12 months, operating cash flow was 72.87 million and capital expenditures -26.98 million, giving a free cash flow of 45.89 million.
| Operating Cash Flow | 72.87M |
| Capital Expenditures | -26.98M |
| Depreciation & Amortization | 33.36M |
| Net Borrowing | -13.68M |
| Free Cash Flow | 45.89M |
| FCF Per Share | 4.10 |
Margins
Gross margin is 22.76%, with operating and profit margins of 6.00% and 5.97%.
| Gross Margin | 22.76% |
| Operating Margin | 6.00% |
| Pretax Margin | 7.96% |
| Profit Margin | 5.97% |
| EBITDA Margin | 9.58% |
| EBIT Margin | 6.00% |
| FCF Margin | 4.93% |
Dividends & Yields
This stock pays an annual dividend of 1.99, which amounts to a dividend yield of 3.56%.
| Dividend Per Share | 1.99 |
| Dividend Yield | 3.56% |
| Dividend Growth (YoY) | 62.87% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 24.56% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.56% |
| Earnings Yield | 8.98% |
| FCF Yield | 7.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
Ilex Medical has an Altman Z-Score of 3.98 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.98 |
| Piotroski F-Score | 6 |